Effect of Vitex negundo L. seeds in letrozole induced polycystic ovarian syndrome

10.1016/j.jtcme.2018.03.001

Nimisha Kakadia；Payal Patel；Shrikalp Deshpande；Gaurang Shah

Polycystic ovary syndrome ； Letrozole ； Vitex negundo ； Insulin resistance ； Estrogen

Journal of Traditional and Complementary Medicine

9卷4期（2019 / 10 / 01）

336 - 345

英文

The clinical management of PCOS is multifaceted but often unsatisfactory. The aim of the current study is to evaluate the effect of Vitex negundo L. in the letrozole-induced polycystic ovarian syndrome. Female Sprague-Dawley rats were divided into six groups, each containing 6 animals. Group I (Control) daily received 1% carboxymethylcellulose (CMC) suspension as a vehicle control. Letrozole (1 mg/kg) was administered per orally (p.o) for a period of 21 days for the induction of PCOS in Group II to VI. PCOS induced animals were treated with aqueous (Group III - 200 mg/kg and IV- 400 mg/kg) and hydro-alcoholic extract (Group V- 200 mg/kg and VI- 400 mg/kg) of Vitex negundo up to 66 days using 0.5% w/v CMC as the vehicle. Body weight and estrous cycle phase were measured every day. Blood samples were collected on 0, 21 and 66 days for the measurement of fasting blood glucose, lipid profile, LH, FSH and hormonal level. Oral glucose tolerance test was performed to study insulin resistance effect. Toxicity markers; SGOT, SGPT, and creatinine also measured at the end of the study. The administration of Letrozole led to an abnormality in serum sex steroid profile, lipid profile, glucose and estrous cycle. It was able to successfully exert its protective effect by restoring parameters to the normal level and disappearance of cysts in ovaries. This can be attributed to phyto-components present in the extract. The aqueous and hydro-alcoholic extracts of seeds of Vitex negundo showed significant amelioration of Letrozole induced PCOS.

1. Borzoei, A,Rafraf, M,Niromanesh, S,Farzadi, L,Narimani, F,Doostan, F(2018).Effects of cinnamon supplementation on antioxidant status and serum lipids in women with polycystic ovary syndrome.J Tradit Complementary Med,8(1),128-133.
   連結：
2. Hosseinkhani, A,Asadi, N,Pasalar, M,Zarshenas, MM(2018).Traditional Persian Medicine and management of metabolic dysfunction in polycystic ovary syndrome.J Tradit Complementary Med,8(1),17-23.
   連結：
3. Arentz, S,Abbott, JA,Smith, CA,Bensoussan, A(2014).Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenor-rhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.BMC Compl Alternative Med,14(1),1.
4. Arroyo, A,Laughlin, G,Morales, A,Yen, S(1997).Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity 1.J Clin Endocrinol Metab,82(11),3728-3733.
5. Badawy, A,Elnashar, A(2011).Treatment options for polycystic ovary syndrome.Int J Womens Health,3(1),25-35.
6. Barber, T,McCarthy, M,Wass, J,Franks, S(2006).Obesity and polycystic ovary syndrome.Clin Endocrinol,65(2),137-145.
7. Bhargava, S.(1989).Antiandrogenic effects of a flavonoid-rich fraction of Vitex negundo seeds: a histological and biochemical study in dogs.J Ethnopharmacol,27(3),327-339.
8. Chang, C-C,Yang, M-H,Wen, H-M,Chern, J-C(2002).Estimation of total flavonoid content in propolis by two complementary colorimetric methods.J Food Drug Anal,10(3)
9. Cheung, AP,Chang, RJ(1995).Endocrinology: pituitary responsiveness to gonadotrophin-releasing hormone agonist stimulation: a dose-response comparison of luteinizing hormone/follicle-stimulating hormone secretion in women with polycystic ovary syndrome and normal women.Hum Reprod,10(5),1054-1059.
10. Choi, S-H,Shapiro, H,Robinson, GE(2005).Psychological side-effects of clomiphene citrate and human menopausal gonadotrophin.J Psychosom Obstet Gynecol,26(2),93-100.
11. Clark, A,Ledger, W,Galletly, C(1995).Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women.Hum Reprod,10(10),2705-2712.
12. Dharmasiri, M,Jayakody, J,Galhena, G,Liyanage, S,Ratnasooriya, W(2003).Anti-inflammatory and analgesic activities of mature fresh leaves of Vitex negundo.J Ethnopharmacol,87(2),199-206.
13. Du Vigneaud V, Karr WG. Carbohydrate utilization I. Rate of disappearance of d-glucose from the blood. J Biol Chem. 1925;66(1):281-300.
14. Dunaif, A(2008).Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndromeda reappraisal.Nat Rev Endocrinol,4(5),272-283.
15. Eden, J,Jones, J,Carter, G,Alaghband-Zadeh, J(1990).Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex-steroids in volume matched normal and polycystic human follicles.Clin Endocrinol,32(4),395-405.
16. Ehrmann, DA(2005).Polycystic ovary syndrome.N Engl J Med.,352(12),1223-1236.
17. Franks, S.(2002).Adult polycystic ovary syndrome begins in childhood.Best Pract Res Clin Endocrinol Metabol,16(2),263-272.
18. Gagnon, C,Baillargeon, J-P(2007).Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome.Can Med Assoc J.,176(7),933-938.
19. Gambineri, A,Pelusi, C,Vicennati, V,Pagotto, U,Pasquali, R(2002).Obesity and the polycystic ovary syndrome.Int J Obes Relat Metab Disord,26(7)
20. Gougeon, A(1996).Regulation of ovarian follicular development in primates: facts and hypotheses.Endocr Rev,17(2),121-155.
21. Hillier, SG,Reichert, LE, Jr,Van hall, EV(1981).Control of preovulatory follicular estrogen biosynthesis in the human ovary.J Clin Endocrinol Metab,52(5),847-856.
22. Holte, J,Bergh, T,Berne, C,Berglund, L,Lithell, H(1994).Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance.J Clin Endocrinol Metab,78(5),1052-1058.
23. Hu, Y,Zhang, Q-Y,Hou, T-T(2007).Estrogen-like activities in Vitex species from China determined by a cell based proliferation assay.Pharmazie,62(11),872-875.
24. Kafali, H,Iriadam, M,Ozardalı, I,Demir, N(2004).Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease.Arch Med Res.,35(2),103-108.
25. Karunamoorthi, K,Ramanujam, S,Rathinasamy, R(2008).Evaluation of leaf extracts of Vitex negundo L. (Family: verbenaceae) against larvae of Culex tritaenio-rhynchus and repellent activity on adult vector mosquitoes.Parasitol Res.,103(3),545-550.
26. Kulkarni, RR,Virkar, AD,D'Mello, P(2008).Antioxidant and antiinflammatory activity of Vitex negundo.Indian J Pharmaceut Sci.,70(6),838-840.
27. Legro, RS,Gnatuk, CL,Kunselman, AR,Dunaif, A(2005).Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.J Clin Endocrinol Metab,90(6),3236-3242.
28. Legro, RS,Kunselman, AR,Dunaif, A(2001).Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.Am J Med.,111(8),607-613.
29. Mahajan, DK(1988).Polycystic ovarian disease: animal models.Endocrinol Metab Clin N Am,17(4),705-732.
30. Maharjan, R,Nagar, PS,Nampoothiri, L(2010).Effect of Aloe barbadensis Mill. formulation on Letrozole induced polycystic ovarian syndrome rat model.J Ayurveda Integr Med,1(4),273-279.
31. Mahesh, VB,Mills, TM,Bagnell, CA,Conway, BA(1987).Animal models for study of polycystic ovaries and ovarian atresia.Adv Exp Med Biol,219,237-257.
32. Medhi, B,Prakash, A.(2010).Practical Manual of Experimental and Clinical Pharmacology.Jaypee Brothers, Medical Publishers Pvt. Limited.
33. Meena, AK,Niranjan, U,Rao, M,Padhi, M,Babu, R(2011).A review of the important chemical constituents and medicinal uses of Vitex genus.Asian J Tradit Med,6(2),54-60.
34. Naessen, S,Carlstrom, K,Bystrom, B,Pierre, Y,Hirschberg, AL(2007).Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women.Psychoneuroendocrinology,32(5),548-554.
35. Petchi, RR,Vijaya, C,Parasuraman, S(2014).Antidiabetic activity of polyherbal formulation in streptozotocin - nicotinamide induced diabetic wistar rats.J Tradit Complementary Med,4(2),108-117.
36. Poretsky, L,Clemons, J,Bogovich, K(1992).Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats.Metabolism,41(8),903-910.
37. Ried, K.(2015).Chinese herbal medicine for female infertility: an updated meta-analysis.Compl Ther Med,23(1),116-128.
38. Robertson, DM,Foulds, LM,Fry, RC,Cummins, JT,Clarke, I(1991).Circulating half-lives of follicle-stimulating hormone and luteinizing hormone in pituitary extracts and isoform fractions of ovariectomized and intact ewes.Endocrine.,129(4),1805-1813.
39. Roy, M,Yasmin, S(2009).Changing concepts in polycystic ovarian syndrome.Apollo Med,6(3),222-226.
40. Sarvankumar, G,Lalitha, V,Sengottuvelu, S,Sharif, SH,Sivakumar, T(2011).Nephroprotective activity of Vitex negundo Linn bark against chemical induced toxicity in experimenal Rats.Int J Adv Pharmaceut Sci.,2,462-470.
41. Sathiamoorthy, B,Gupta, P,Kumar, M,Chaturvedi, AK,Shukla, PK,Maurya, R(2007).New antifungal flavonoid glycoside from Vitex negundo.Bioorg Med Chem Lett,17(1),239-242.
42. Shivanandappa, T,Venkatesh, S(1997).A colorimetric assay method for 3β-hydroxy-Δ 5-steroid dehydrogenase.Anal Chem,254(1),57-61.
43. Sundaram, R,Naresh, R,Shanthi, P,Sachdanandam, P(2012).Antihyperglycemic effect of iridoid glucoside, isolated from the leaves of Vitex negundo in streptozotocin-induced diabetic rats with special reference to glycoprotein components.Phytomedicine,19(3-4),211-216.
44. Sundblad, C,Bergman, L,Eriksson, E(1994).High levels of free testosterone in women with bulimia nervosa.Acta Psychiatr Scand,90(5),397-398.
45. Tandon, VR(2005).Medicinal uses and biological activities of Vitex negundo.Nat Prod Radiance,4(3),162-165.
46. Taylor, AE,McCourt, B,Martin, KA(1997).Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome 1.J Clin Endocrinol Metab,82(7),2248-2256.
47. Vishwanathan, A,Basavaraju, R(2010).A review on Vitex negundo L-a medicinally important plant.Eur J Biol Sci.,3(1),30-42.
48. Wang, F,Yu, B,Yang, W,Liu, J,Lu, J,Xia, X(2012).Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats.J Ovarian Res,5(1),1.
49. welfare MohaF(ed.).Ayurvedic Pharmacopiea of India.India:
50. Xiang, S-K,Hua, F,Tang, Y,Jiang, X-H,Zhuang, Q,Qian, F-J.(2012).Relationship between serum lipoprotein ratios and insulin resistance in polycystic ovary syndrome.Internet J Endocrinol,2012

1. Madhavi Patel,Disha P. Prajapati,Abhay Dharamsi(2022).Beneficial effect of polyherbal formulation in letrozole induced Polycystic ovarian syndrome (PCOS).Journal of Traditional and Complementary Medicine,12(6),575-583.